ALZN Valuation

Alzamend Neuro Inc

Add to Watchlist

Advanced Chart

2.960

-0.03(-1.003%)1D

Overview
Forecast
Valuation
Earnings

ALZN Relative Valuation

ALZN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ALZN is overvalued; if below, it's undervalued.

Historical Valuation

Alzamend Neuro Inc (ALZN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -22.02. The fair price of Alzamend Neuro Inc (ALZN) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：2.96

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.58

P/B

Median3y

-16.15

Median5y

-1.20

-79.31

FCF Yield

Median3y

-108.44

Median5y

-79.95

Competitors Valuation Multiple

The average P/S ratio for ALZN's competitors is 0.00, providing a benchmark for relative valuation. Alzamend Neuro Inc Corp (ALZN) exhibits a P/S ratio of 0.00, which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap